{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T10:41:02Z","timestamp":1767177662570,"version":"build-2238731810"},"update-to":[{"DOI":"10.1371\/journal.pntd.0012898","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000}}],"reference-count":67,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01 NS110122"],"award-info":[{"award-number":["R01 NS110122"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01 NS110122"],"award-info":[{"award-number":["R01 NS110122"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01 NS110122"],"award-info":[{"award-number":["R01 NS110122"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bart McClean Fund for Neuroimmunology Research"},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["734584"],"award-info":[{"award-number":["734584"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["734584"],"award-info":[{"award-number":["734584"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["734584"],"award-info":[{"award-number":["734584"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["092805"],"award-info":[{"award-number":["092805"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["202789"],"award-info":[{"award-number":["202789"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Zika produced the highest increase in the incidence of Guillain-Barr\u00e9 syndrome (GBS) in Latin America in the last decade. The Neuroinfections Emerging in the Americas Study (NEAS) was established in 2016 to investigate the association of emerging infectious disorders with GBS in Colombia. The present study assessed the role of preceding infections, including arboviruses and other pathogens, as risk factors for GBS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A case-control study was conducted prospectively between June 2016 and December 2019 in 5 Colombian cities. We recruited newly diagnosed patients with GBS and a house control plus an age and season-matched-hospital control per case. Clinical information, blood, CSF, and urine samples were used to diagnose bacterial and viral infections. Anti-glycolipid antibodies were identified in serum. Statistical analyses were performed using conditional logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>\n                      Fifty-seven patients with GBS, 66\u00b77% male, 52 years of median age, were recruited along with 77 (55 house and 22 hospital) controls. GBS was associated with presenting diarrhea (adjusted OR 10\u00b794; 95% CI 1\u00b78-66\u00b729; p=0\u00b7009) and a history of recent upper respiratory tract infection (aOR 13\u00b791; 95% CI 2\u00b738-81\u00b71 p=0\u00b7003). Specific recent infections did not significantly differ between cases and controls, but the number of infections was associated with GBS (aOR=1\u00b777 95% CI 1\u00b704-3\u00b701 p=0\u00b703).\n                      <jats:italic>C. jejuni<\/jats:italic>\n                      (74%),\n                      <jats:italic>M. pneumoniae<\/jats:italic>\n                      (23%), and Chikungunya (7%) were the most frequent infections. Anti-glycolipid IgG against GM1 and their heterodimer complexes were identified to be associated with GBS.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>After the Zika epidemic, infections causing diarrhea and upper respiratory diseases contributed to the burden of GBS in Colombia. Prevention and control of food-borne pathogens could reduce the incidence of GBS in Colombia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pntd.0012898","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T17:11:43Z","timestamp":1743441103000},"page":"e0012898","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Guillain-Barr\u00e9 syndrome after the Zika epidemic in Colombia: A multicenter, matched case-control study"],"prefix":"10.1371","volume":"19","author":[{"given":"Lyda","family":"Osorio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Parra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Moyano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reydmar","family":"Lopez-Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge A.","family":"Jimenez-Arango","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Vargas-Manotas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jairo","family":"Lizarazo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo E.","family":"Ramos-Burbano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario Daniel","family":"Llanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Rosso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Urrego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan P.","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian A.","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Benavides-Melo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viviana A.","family":"Martinez-Villota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina A.","family":"Luque-Burgos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana M.","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliana","family":"Soto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Quintero-Corzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime A.","family":"Quintero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Zuluaga-Lotero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Acero-Garces","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana C.","family":"Dominguez-Pe\u00f1uela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Halstead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugh J.","family":"Willison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos A.","family":"Pardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"On behalf of the Neuroinfections Emerging in the Americas Study (NEAS)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"issue":"10045","key":"pntd.0012898.ref001","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"388","author":"HJ Willison","year":"2016","journal-title":"Lancet"},{"issue":"8","key":"pntd.0012898.ref002","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain-Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis","volume":"10","author":"B van den Berg","year":"2014","journal-title":"Nat Rev Neurol"},{"issue":"12","key":"pntd.0012898.ref003","doi-asserted-by":"crossref","first-page":"e1299","DOI":"10.1212\/WNL.0000000000200885","article-title":"An international perspective on preceding infections in Guillain-Barr\u00e9 syndrome: the IGOS-1000 cohort","volume":"99","author":"SE Leonhard","year":"2022","journal-title":"Neurology"},{"issue":"10027","key":"pntd.0012898.ref004","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","article-title":"Guillain-Barr\u00e9 Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study","volume":"387","author":"V-M Cao-Lormeau","year":"2016","journal-title":"Lancet"},{"issue":"16","key":"pntd.0012898.ref005","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1056\/NEJMc1609015","article-title":"Zika virus and the Guillain-Barr\u00e9 syndrome - case series from seven countries","volume":"375","author":"T Dos Santos","year":"2016","journal-title":"N Engl J Med"},{"issue":"16","key":"pntd.0012898.ref006","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1605564","article-title":"Guillain-Barr\u00e9 syndrome associated with Zika virus infection in Colombia","volume":"375","author":"B Parra","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"pntd.0012898.ref007","doi-asserted-by":"crossref","first-page":"e952","DOI":"10.1212\/NXI.0000000000000952","article-title":"Guillain-Barr\u00e9 syndrome outbreak in Peru 2019 associated with campylobacter Jejuni infection","volume":"8","author":"AP Ramos","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"3","key":"pntd.0012898.ref008","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","article-title":"Guillain-Barr\u00e9 syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"29","author":"JJ Sejvar","year":"2011","journal-title":"Vaccine"},{"issue":"9","key":"pntd.0012898.ref009","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrneurol.2014.138","article-title":"Guillain-Barr\u00e9 and Miller Fisher syndromes--new diagnostic classification","volume":"10","author":"GBS Classification Group.","year":"2014","journal-title":"Nat Rev Neurol"},{"issue":"8093","key":"pntd.0012898.ref010","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","article-title":"Controlled trial prednisolone in acute polyneuropathy","volume":"2","author":"RA Hughes","year":"1978","journal-title":"Lancet"},{"issue":"5","key":"pntd.0012898.ref011","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","article-title":"Interobserver agreement for the assessment of handicap in stroke patients","volume":"19","author":"JC van Swieten","year":"1988","journal-title":"Stroke"},{"issue":"11","key":"pntd.0012898.ref012","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/mus.880141111","article-title":"Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barr\u00e9 syndrome","volume":"14","author":"RP Kleyweg","year":"1991","journal-title":"Muscle Nerve"},{"issue":"5","key":"pntd.0012898.ref013","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ana.410440512","article-title":"Electrophysiological classification of Guillain-Barr\u00e9 syndrome: clinical associations and outcome. Plasma Exchange\/Sandoglobulin Guillain-Barr\u00e9 Syndrome Trial Group","volume":"44","author":"RD Hadden","year":"1998","journal-title":"Ann Neurol"},{"issue":"8","key":"pntd.0012898.ref014","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3201\/eid1408.080287","article-title":"Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007","volume":"14","author":"RS Lanciotti","year":"2008","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"pntd.0012898.ref015","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3201\/eid2207.160326","article-title":"Single-reaction multiplex reverse transcription PCR for detection of Zika, Chikungunya, and dengue viruses","volume":"22","author":"JJ Waggoner","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"pntd.0012898.ref016","doi-asserted-by":"crossref","first-page":"764","DOI":"10.3201\/eid1305.070015","article-title":"Chikungunya virus in US travelers returning from India, 2006","volume":"13","author":"RS Lanciotti","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"pntd.0012898.ref017","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1128\/jcm.30.3.545-551.1992","article-title":"Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction","volume":"30","author":"RS Lanciotti","year":"1992","journal-title":"J Clin Microbiol"},{"key":"pntd.0012898.ref018","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1186\/1743-422X-7-361","article-title":"Comparison of the diagnostic accuracy of commercial NS1-based diagnostic tests for early dengue infection","volume":"7","author":"L Osorio","year":"2010","journal-title":"Virol J"},{"key":"pntd.0012898.ref019","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jcv.2017.05.001","article-title":"Re-evaluation of routine dengue virus serology in travelers in the era of Zika virus emergence","volume":"92","author":"MPA van Meer","year":"2017","journal-title":"J Clin Virol"},{"issue":"4","key":"pntd.0012898.ref020","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3390\/tropicalmed8040224","article-title":"Trends in ELISA-based Flavivirus IgG Serosurveys: a systematic review","volume":"8","author":"FES Vista","year":"2023","journal-title":"Trop Med Infect Dis"},{"issue":"3","key":"pntd.0012898.ref021","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/BF01962343","article-title":"Human serum antibody response in Campylobacter jejuni enteritis as measured by enzyme-linked immunosorbent assay","volume":"7","author":"P Herbrink","year":"1988","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"pntd.0012898.ref022","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1212\/WNL.56.6.758","article-title":"Preceding infections, immune factors, and outcome in Guillain-Barr\u00e9 syndrome","volume":"56","author":"RD Hadden","year":"2001","journal-title":"Neurology"},{"issue":"2","key":"pntd.0012898.ref023","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.410400209","article-title":"Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barr\u00e9 syndrome","volume":"40","author":"BC Jacobs","year":"1996","journal-title":"Ann Neurol"},{"issue":"4","key":"pntd.0012898.ref024","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1046\/j.1469-0691.2003.00590.x","article-title":"Laboratory diagnosis of Mycoplasma pneumoniae infection","volume":"9","author":"F Daxboeck","year":"2003","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"pntd.0012898.ref025","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1128\/cdli.4.4.469-473.1997","article-title":"Avidity of immunoglobulin G directed against human cytomegalovirus during primary and secondary infections in immunocompetent and immunocompromised subjects","volume":"4","author":"T Lazzarotto","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"issue":"1","key":"pntd.0012898.ref026","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5501\/wjv.v1.i1.31","article-title":"Serological diagnosis of Epstein-Barr virus infection: Problems and solutions","volume":"1","author":"M De Paschale","year":"2012","journal-title":"World J Virol"},{"issue":"6","key":"pntd.0012898.ref027","doi-asserted-by":"crossref","first-page":"e284","DOI":"10.1212\/NXI.0000000000000284","article-title":"Microarray screening of Guillain-Barr\u00e9 syndrome sera for antibodies to glycolipid complexes","volume":"3","author":"SK Halstead","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"pntd.0012898.ref028","author":"Team R.","year":"2020"},{"issue":"4","key":"pntd.0012898.ref029","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1474-4422(20)30494-4","article-title":"Second intravenous immunoglobulin dose in patients with Guillain-Barr\u00e9 syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial","volume":"20","author":"C Walgaard","year":"2021","journal-title":"Lancet Neurol"},{"issue":"12","key":"pntd.0012898.ref030","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1111\/ene.16073","article-title":"European Academy of Neurology\/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barr\u00e9 syndrome","volume":"30","author":"PA van Doorn","year":"2023","journal-title":"Eur J Neurol"},{"key":"pntd.0012898.ref031","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jaut.2016.12.007","article-title":"A comprehensive analysis and immunobiology of autoimmune neurological syndromes during the Zika virus outbreak in C\u00facuta, Colombia","volume":"77","author":"J-M Anaya","year":"2017","journal-title":"J Autoimmun"},{"issue":"15","key":"pntd.0012898.ref032","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1001\/jama.2017.11483","article-title":"Acute Zika virus infection as a risk factor for Guillain-Barr\u00e9 syndrome in Puerto Rico","volume":"318","author":"E Dirlikov","year":"2017","journal-title":"JAMA"},{"issue":"4","key":"pntd.0012898.ref033","first-page":"339","article-title":"Role of SARS-CoV-2 neurotropism and neuroinvasion in COVID-19 patients disease severity","volume":"156","author":"I Grijalva-Otero","year":"2020","journal-title":"Gac Med Mex"},{"issue":"3","key":"pntd.0012898.ref034","doi-asserted-by":"crossref","first-page":"e0230132","DOI":"10.1371\/journal.pone.0230132","article-title":"Zika Virus infection and Guillain-Barr\u00e9 syndrome in Northeastern Mexico: a case-control study","volume":"15","author":"F Gongora-Rivera","year":"2020","journal-title":"PLoS One"},{"key":"pntd.0012898.ref035","doi-asserted-by":"crossref","first-page":"117272","DOI":"10.1016\/j.jns.2020.117272","article-title":"Guillain-Barr\u00e9 syndrome during the Zika virus outbreak in Northeast Brazil: an observational cohort study","volume":"420","author":"SE Leonhard","year":"2021","journal-title":"J Neurol Sci"},{"issue":"3","key":"pntd.0012898.ref036","first-page":"137","article-title":"Guillain-Barr\u00e9 syndrome: association with Campylobacter jejuni and Mycoplasma pneumoniae infections in India","volume":"19","author":"SP Gorthi","year":"2006","journal-title":"Natl Med J India"},{"issue":"Pt 12","key":"pntd.0012898.ref037","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/brain\/awf272","article-title":"Peripheral neuropathies and anti-glycolipid antibodies","volume":"125","author":"HJ Willison","year":"2002","journal-title":"Brain"},{"issue":"22","key":"pntd.0012898.ref038","doi-asserted-by":"crossref","first-page":"14222","DOI":"10.3390\/ijms232214222","article-title":"Triggers of Guillain-Barr\u00e9 Syndrome: Campylobacter jejuni Predominates","volume":"23","author":"J Finsterer","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"2","key":"pntd.0012898.ref039","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/tmi.13181","article-title":"Systematic review of factors associated with the development of Guillain-Barr\u00e9 syndrome 2007-2017: what has changed?","volume":"24","author":"VK Wachira","year":"2019","journal-title":"Trop Med Int Health"},{"issue":"1","key":"pntd.0012898.ref040","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00415-022-11331-4","article-title":"Clinical features of Guillain-Barr\u00e9 syndrome and factors associated with mortality during the 2019 outbreak in Peru","volume":"270","author":"MF Reyes-Vega","year":"2023","journal-title":"J Neurol"},{"issue":"7","key":"pntd.0012898.ref041","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1212\/WNL.0b013e3181cff735","article-title":"Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh","volume":"74","author":"Z Islam","year":"2010","journal-title":"Neurology"},{"issue":"6","key":"pntd.0012898.ref042","doi-asserted-by":"crossref","first-page":"e831","DOI":"10.1212\/WNL.0000000000011342","article-title":"Association of Hospital-Diagnosed Infections and Antibiotic Use With Risk of Developing Guillain-Barr\u00e9 Syndrome","volume":"96","author":"LS Levison","year":"2021","journal-title":"Neurology"},{"issue":"11","key":"pntd.0012898.ref043","first-page":"2539","article-title":"Study of Guillain-Barre syndrome etiology in Pakistani patients","volume":"71","author":"R Iqbal","year":"2021","journal-title":"J Pak Med Assoc"},{"issue":"6","key":"pntd.0012898.ref044","first-page":"912","article-title":"Guillain-Barr\u00e9 syndrome. Clinical manifestations and directions for treatment","volume":"49","author":"J Rees","year":"1995","journal-title":"Drugs"},{"key":"pntd.0012898.ref045","first-page":"597","article-title":"Guillain-Barr\u00e9 syndrome in Northern China. Relationship to Campylobacter Jejuni infection and anti-glycolipid antibodies","author":"TW Ho","year":"1995","journal-title":"Brain"},{"issue":"4","key":"pntd.0012898.ref046","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1371\/journal.pone.0000344","article-title":"Guillain-Barr\u00e9 syndrome and preceding infection with campylobacter, influenza and Epstein-Barr virus in the general practice research database","volume":"2","author":"CC Tam","year":"2007","journal-title":"PLoS One"},{"issue":"5","key":"pntd.0012898.ref047","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1017\/S0950268813001908","article-title":"Binational outbreak of Guillain-Barr\u00e9 syndrome associated with Campylobacter jejuni infection, Mexico and USA, 2011","volume":"142","author":"BR Jackson","year":"2014","journal-title":"Epidemiol Infect"},{"issue":"3","key":"pntd.0012898.ref048","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/jns.12459","article-title":"Antecedent infections in Guillain-Barr\u00e9 syndrome patients from south India","volume":"26","author":"D Dutta","year":"2021","journal-title":"J Peripher Nerv Syst"},{"issue":"5","key":"pntd.0012898.ref049","doi-asserted-by":"crossref","first-page":"717","DOI":"10.4103\/0028-3886.86547","article-title":"Campylobacter jejuni infection in Guillain-Barr\u00e9 syndrome: a prospective case control study in a tertiary care hospital","volume":"59","author":"A Sharma","year":"2011","journal-title":"Neurol India"},{"issue":"12","key":"pntd.0012898.ref050","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1002\/acn3.50946","article-title":"Antecedent infections in Guillain-Barr\u00e9 syndrome: a single-center, prospective study","volume":"6","author":"Y Hao","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"issue":"5","key":"pntd.0012898.ref051","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/QCO.0000000000000570","article-title":"A One Health approach to prevention, treatment, and control of campylobacteriosis","volume":"32","author":"F Schiaffino","year":"2019","journal-title":"Curr Opin Infect Dis"},{"issue":"3","key":"pntd.0012898.ref052","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1128\/CMR.11.3.555","article-title":"Campylobacter species and Guillain-Barr\u00e9 syndrome","volume":"11","author":"I Nachamkin","year":"1998","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"pntd.0012898.ref053","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2016.21.4.30119","article-title":"Cluster of atypical adult Guillain-Barr\u00e9 syndrome temporally associated with neurological illness due to EV-D68 in children, South Wales, United Kingdom, October 2015 to January 2016","volume":"21","author":"CJ Williams","year":"2016","journal-title":"Euro Surveill"},{"issue":"9","key":"pntd.0012898.ref054","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1468-1331.2006.01390.x","article-title":"A case-control study of Guillain-Barr\u00e9 syndrome in Harbin, China","volume":"13","author":"Q Cheng","year":"2006","journal-title":"Eur J Neurol"},{"issue":"1","key":"pntd.0012898.ref055","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3201\/eid2301.161290","article-title":"Guillain-Barr\u00e9 syndrome and healthcare needs during Zika virus transmission, Puerto Rico, 2016","volume":"23","author":"E Dirlikov","year":"2017","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"pntd.0012898.ref056","doi-asserted-by":"crossref","first-page":"356","DOI":"10.4269\/ajtmh.15-0753","article-title":"Guillain-Barr\u00e9 syndrome and Chikungunya: description of all cases diagnosed during the 2014 outbreak in the French West Indies","volume":"97","author":"S Balavoine","year":"2017","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"pntd.0012898.ref057","doi-asserted-by":"crossref","first-page":"e833","DOI":"10.1212\/NXI.0000000000000833","article-title":"High proportion of Guillain-Barr\u00e9 syndrome associated with chikungunya in Northeast Brazil","volume":"7","author":"MB Matos A de","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"4","key":"pntd.0012898.ref058","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","article-title":"The spectrum of antecedent infections in Guillain-Barr\u00e9 syndrome: a case-control study","volume":"51","author":"BC Jacobs","year":"1998","journal-title":"Neurology"},{"issue":"7","key":"pntd.0012898.ref059","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/cid\/cir074","article-title":"Guillain-Barr\u00e9 syndrome following primary cytomegalovirus infection: a prospective cohort study","volume":"52","author":"D Orlikowski","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"5","key":"pntd.0012898.ref060","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1086\/655136","article-title":"Increased risk of Guillain-Barr\u00e9 Syndrome following recent herpes zoster: a population-based study across Taiwan","volume":"51","author":"J-H Kang","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"12","key":"pntd.0012898.ref061","doi-asserted-by":"crossref","first-page":"5304","DOI":"10.1080\/21645515.2021.1985890","article-title":"Risk of Guillain-Barr\u00e9 syndrome following herpes zoster, United States, 2010-2018","volume":"17","author":"TC Anderson","year":"2021","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"pntd.0012898.ref062","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/jmv.23827","article-title":"Serological cross reactivity to CMV and EBV causes problems in the diagnosis of acute hepatitis E virus infection","volume":"86","author":"C Hyams","year":"2014","journal-title":"J Med Virol"},{"issue":"15","key":"pntd.0012898.ref063","doi-asserted-by":"crossref","first-page":"e1555","DOI":"10.1212\/WNL.0000000000200015","article-title":"Association between incident cancer and Guillain-Barr\u00e9 syndrome development: a nationwide case-control study","volume":"98","author":"LS Levison","year":"2022","journal-title":"Neurology"},{"issue":"10","key":"pntd.0012898.ref064","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1111\/ene.15955","article-title":"Hospital-diagnosed morbidities and recent surgery as risk factors for developing Guillain-Barr\u00e9 syndrome","volume":"30","author":"LS Levison","year":"2023","journal-title":"Eur J Neurol"},{"issue":"4","key":"pntd.0012898.ref065","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/ana.20222","article-title":"Ganglioside complexes as new target antigens in Guillain-Barr\u00e9 syndrome","volume":"56","author":"K Kaida","year":"2004","journal-title":"Ann Neurol"},{"key":"pntd.0012898.ref066","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-1-0716-2148-6_11","article-title":"Detection of autoantibodies using combinatorial glycolipid microarrays","author":"SK Halstead","year":"2022","journal-title":"Methods Mol Biol"},{"key":"pntd.0012898.ref067","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jneuroim.2014.11.001","article-title":"Improving the detection of IgM antibodies against glycolipids complexes of GM1 and Galactocerebroside in Multifocal Motor Neuropathy using glycoarray and ELISA assays","volume":"278","author":"E Delmont","year":"2015","journal-title":"J Neuroimmunol"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0012898","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0012898","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T17:13:37Z","timestamp":1743441217000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0012898"}},"subtitle":[],"editor":[{"given":"Guilherme L","family":"Werneck","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":67,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0012898","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]}}}